EGM
EGRX

Engineers Gate Manager’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Engineers Gate Manager’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,922
Closed -$72.8K – 2383
2023
Q4 		$72.8K Buy
+13,922
New +$137K ﹤0.01% 1810
2022
Q3 		– Sell
-9,767
Closed -$434K – 2165
2022
Q2 		$434K Buy
9,767
+4,448
+84% +$204K 0.02% 1189
2022
Q1 		$263K Buy
+5,319
New +$255K 0.01% 1486
2021
Q3 		– Sell
-10,034
Closed -$429K – 2048
2021
Q2 		$429K Sell
10,034
-7,314
-42% -$302K 0.03% 923
2021
Q1 		$724K Buy
17,348
+564
+3% +$26.2K 0.04% 754
2020
Q4 		$782K Sell
16,784
-10,934
-39% -$511K 0.03% 711
2020
Q3 		$1.18M Buy
27,718
+6,434
+30% +$281K 0.06% 528
2020
Q2 		$1.02M Sell
21,284
-8,501
-29% -$424K 0.05% 587
2020
Q1 		$1.37M Buy
29,785
+20,425
+218% +$1.02M 0.1% 294
2019
Q4 		$562K Sell
9,360
-10,864
-54% -$648K 0.02% 936
2019
Q3 		$1.14M Buy
+20,224
New +$1.14M 0.06% 492
2019
Q2 		– Sell
-23,459
Closed -$1.18M – 1421
2019
Q1 		$1.18M Sell
23,459
-8,681
-27% -$386K 0.07% 397
2018
Q4 		$1.29M Buy
32,140
+7,345
+30% +$379K 0.1% 296
2018
Q3 		$1.72M Buy
24,795
+860
+4% +$65.2K 0.13% 250
2018
Q2 		$1.81M Buy
+23,935
New +$1.51M 0.14% 235
2017
Q3 		– Sell
-5,632
Closed -$444K – 848
2017
Q2 		$444K Buy
+5,632
New +$461K 0.04% 526
2017
Q1 		– Sell
-9,665
Closed -$767K – 794
2016
Q4 		$767K Buy
+9,665
New +$702K 0.08% 372

Other funds holding EGRX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Engineers Gate Manager's EGRX Position: Q1 2024 in Review

Engineers Gate Manager sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2024, closing a stake of 13,922 shares — an estimated $72.8K sold.

Engineers Gate Manager first reported a position in EGRX in Q4 2016 and held it in 17 quarters. The position peaked at $1.81M in Q2 2018. 91 funds tracked by Wall St. Rank hold EGRX as of Q1 2024.

  • Engineers Gate Manager reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 13,922 Eagle Pharmaceuticals, Inc. shares in Q1 2024, an estimated $72.8K.
  • Engineers Gate Manager first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2016 and held it in 17 quarters.
  • Engineers Gate Manager's Eagle Pharmaceuticals, Inc. position peaked at $1.81M in Q2 2018.
  • 91 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.